Welcome to the world of immunohistochemistry!
📞 800-8581156 📧 info@naim.com.cn
Menu
  • Home
  • Product
  • Service and Support
    • Immunohistochemistry and Pathology
    • Immunohistochemistry Technology Exchange
    • Recommended List and Introduction of Newly Developed IHC
    • Public laboratory
    • Consultation and Feedback
  • News and Information
    • Hotspot Focus
    • Industry News
    • Maxxin Dynamics
    • Meeting Notice
  • Entering Maixin
    • Corporate Culture
    • Maisin Honors
    • Maixin Company Profile
    • Myriad Pathology Foundation Overview
  • Contact us
Close
分类
  • Consultation and Feedback
  • Hotspot Focus
  • Immunohistochemistry and Pathology
  • Immunohistochemistry Technology Exchange
  • Industry News
  • Maxxin Dynamics
  • Meeting Notice
  • News and Information
  • Public laboratory
  • Recommended List and Introduction of Newly Developed IHC
  • Service and Support
  • Uncategorized
Product Search
06 2 月

Precision Prevention and Treatment, Comprehensive Management: 2020 Annual Meeting of Fudan Zhongshan Cancer Prevention and Treatment Center

Continue reading
06 2 月

Twenty-fourth Issue of “Mai Mai” Pathology Weekly Reading Notes | Overview of Immunohistochemical Markers for Peritoneal Tumor Diagnosis

Continue reading
06 2 月

Maimai’s Pathology Weekly Reading Notes Issue 9 | Immunohistochemical Markers for Oral Tumors and Salivary Gland Tumors

Continue reading
06 2 月

Future Prospects at the 2019 National Pathology Conference

Continue reading
06 2 月

Empowering Transformation with Intelligent Depth, Maxinbio’s Diagnostic Reagent Production Base Construction Accelerates!

Continue reading
06 2 月

Warm Congratulations to Professor Bian Xiuwu on His Election as an Academician of the Chinese Academy of Sciences

Continue reading
06 2 月

Striving to Lead Amidst Competition; Persevering with Diligence for Long-term Success — Maixin Company Successfully Holds 2020 Annual Work Summary Meeting

Continue reading
06 2 月

Immunohistochemical Differentiation Chart for Basal Cell Carcinoma vs. Squamous Cell Carcinoma

Continue reading
06 2 月

A Tree of Subtle Flowers Occasionally Brightens: BCOR as an IHC Surrogate Marker for Genomic Alterations in Soft Tissue and Bone Tumors

Continue reading
06 2 月

Endogenous Biotin Blocking Kit

Continue reading
  • «
  • ‹
  • 26
  • 27
  • 28
  • 29
  • 30
  • ›
  • »

Copyright © 1993 - 2017 Fuzhou Maixin Biotechnology Development Co., Ltd. MinICP No. 05015562-1 | (Fujian) - Non-commercial - 2017-0010

  • Home
  • Product
  • Service and Support
    • Immunohistochemistry and Pathology
    • Immunohistochemistry Technology Exchange
    • Recommended List and Introduction of Newly Developed IHC
    • Public laboratory
    • Consultation and Feedback
  • News and Information
    • Hotspot Focus
    • Industry News
    • Maxxin Dynamics
    • Meeting Notice
  • Entering Maixin
    • Corporate Culture
    • Maisin Honors
    • Maixin Company Profile
    • Myriad Pathology Foundation Overview
  • Contact us
Sidebar